Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 3 October 2021
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 3 October 2021. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
Referring to their earlier news disseminated by DSE on 24.01.2021, 05.09.2021 and 14.09.2021 regarding acquisition of a majority stake in Sanofi Bangladesh Limited, the Company has further informed that they have now completed its acquisition of the majority stake in Sanofi Bangladesh Limited. The final consideration, payable in cash (post the closing adjustments previously outlined), was approximately BDT 469.62 crore (Equivalent pound 39.35 million).
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b00004005247a
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.